132 Intermittent dosing of the MEK inhibitor, GDC-0973, and the PI3K inhibitor, GDC-0941, results in prolonged accumulation of Bim and causes strong tumor growth inhibition in vivo

MLA

Leanne Berry, et al. “132 Intermittent Dosing of the MEK Inhibitor, GDC-0973, and the PI3K Inhibitor, GDC-0941, Results in Prolonged Accumulation of Bim and Causes Strong Tumor Growth Inhibition in Vivo.” European Journal of Cancer Supplements, vol. 8, Nov. 2010, p. 48. EBSCOhost, https://doi.org/10.1016/s1359-6349(10)71837-1.

APA

Leanne Berry, Kenneth D. Rice, Mark Merchant, Christine Orr, Hartmut Koeppen, Klaus P. Hoeflich, Marcia Belvin, Jocelyn Chan, D. den Otter, & Lori Friedman. (2010). 132 Intermittent dosing of the MEK inhibitor, GDC-0973, and the PI3K inhibitor, GDC-0941, results in prolonged accumulation of Bim and causes strong tumor growth inhibition in vivo. European Journal of Cancer Supplements, 8, 48. https://doi.org/10.1016/s1359-6349(10)71837-1

Chicago

Leanne Berry, Kenneth D. Rice, Mark Merchant, Christine Orr, Hartmut Koeppen, Klaus P. Hoeflich, Marcia Belvin, Jocelyn Chan, D. den Otter, and Lori Friedman. 2010. “132 Intermittent Dosing of the MEK Inhibitor, GDC-0973, and the PI3K Inhibitor, GDC-0941, Results in Prolonged Accumulation of Bim and Causes Strong Tumor Growth Inhibition in Vivo.” European Journal of Cancer Supplements 8 (November): 48. doi:10.1016/s1359-6349(10)71837-1.